top of page
Search


Vizuro Signs Memorandum of Understanding with Chang Gung University of Science and Technology to Advance AI-Driven Drug Discovery
Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with CGUST Taipei | [August 22, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI  and generative AI  technology, announced today that it has signed a Memorandum of Understanding (MOU) with Tsong-Long Hwang, Ph.D., Vice President and Distinguished Professor at Chang Gung U
Esther Chen
Aug 222 min read
Â


Beyond the Survey: Illuminating Your Medical Affairs Strategy with Polus
Polus is an AI-driven solution for pharmaceutical medical affairs. It analyzes MSL (Medical Science Liaison) engagements with HCPs (Healthcare Professionals) to provide insights beyond traditional, periodic ATU (Awareness, Trial, and Usage) studies. The product uses sentiment analysis, topic analysis, and summarization to give a real-time understanding of HCP perceptions. This continuous feedback loop helps commercial and marketing teams to refine their strategies pre-launch,

Yu-Feng Wei
Aug 72 min read
Â


Evaluating Drug Safety from Real-World Evidence: Congratulating Vizuro Team’s Contribution to Hematology Research
We're excited to share that a recent academic paper co-authored by our Data Scientist. Ling-Yu Cai, along with a team of MD/PhD...

Yu-Feng Wei
Jul 81 min read
Â


Causal Disease Management – Explainable Risk Modeling and Intervention for Diabetes
Empowering Clinicians and General Populations with Actionable Insights Diabetes is one of the world’s fastest-growing health crises,...

Yu-Feng Wei
Mar 253 min read
Â
bottom of page